These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16134318)

  • 1. Sturge-Weber syndrome: diffusion magnetic resonance imaging and proton magnetic resonance spectroscopy findings.
    Cakirer S; Yagmurlu B; Savas MR
    Acta Radiol; 2005 Jul; 46(4):407-10. PubMed ID: 16134318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy in children with Sturge-Weber syndrome.
    Moore GJ; Slovis TL; Chugani HT
    J Child Neurol; 1998 Jul; 13(7):332-5. PubMed ID: 9701482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging.
    Lin DD; Barker PB; Kraut MA; Comi A
    AJNR Am J Neuroradiol; 2003 Oct; 24(9):1912-5. PubMed ID: 14561628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor imaging and magnetic resonance spectroscopy of the brain in a patient with Sturge-Weber syndrome.
    Sijens PE; Gieteling EW; Meiners LC; Sival DA; Potze JH; Irwan R; Oudkerk M
    Acta Radiol; 2006 Nov; 47(9):972-6. PubMed ID: 17077050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowe syndrome: proton mr spectroscopy, and diffusion mr imaging.
    Sener RN
    J Neuroradiol; 2004 Jun; 31(3):238-40. PubMed ID: 15356453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopic imaging detects abnormalities in normal-appearing frontal lobe of patients with Sturge-Weber syndrome.
    Batista CE; Chugani HT; Hu J; Haacke EM; Behen ME; Helder EJ; Juhász C
    J Neuroimaging; 2008 Jul; 18(3):306-13. PubMed ID: 18808656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Zonari P; Baraldi P; Crisi G
    Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms.
    Lin DD; Barker PB; Hatfield LA; Comi AM
    J Magn Reson Imaging; 2006 Aug; 24(2):274-81. PubMed ID: 16786573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion MRI and spectroscopy in Rasmussen's encephalitis.
    Sener RN
    Eur Radiol; 2003 Sep; 13(9):2186-91. PubMed ID: 12928965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging increased glutamate in children with Sturge-Weber syndrome: Association with epilepsy severity.
    Juhász C; Hu J; Xuan Y; Chugani HT
    Epilepsy Res; 2016 May; 122():66-72. PubMed ID: 26970949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.
    Zierhut ML; Ozturk-Isik E; Chen AP; Park I; Vigneron DB; Nelson SJ
    J Magn Reson Imaging; 2009 Sep; 30(3):473-80. PubMed ID: 19711396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.
    Sener RN
    AJNR Am J Neuroradiol; 2003 Sep; 24(8):1690-3. PubMed ID: 13679293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study.
    Nicoli F; Lefur Y; Denis B; Ranjeva JP; Confort-Gouny S; Cozzone PJ
    Stroke; 2003 Jul; 34(7):e82-7. PubMed ID: 12817104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
    Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
    Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metachromatic leukodystrophy. Diffusion MR imaging and proton MR spectroscopy.
    Sener RN
    Acta Radiol; 2003 Jul; 44(4):440-3. PubMed ID: 12846696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of quantitative cerebral T2 relaxometry, diffusion tensor imaging, and 1H magnetic resonance spectroscopy at 3.0 Tesla.
    Jansen JF; Kooi ME; Kessels AG; Nicolay K; Backes WH
    Invest Radiol; 2007 Jun; 42(6):327-37. PubMed ID: 17507802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance imaging and magnetic resonance spectroscopy in the evaluation of focal cerebral tubercular lesions.
    Batra A; Tripathi RP
    Acta Radiol; 2004 Oct; 45(6):679-88. PubMed ID: 15587429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.